Abstract. Worldwide, the highest prevalence of esophageal cancer (EC) occurs in Northern China. High-density SNP arrays allow identification of identity-by-descent (IBD) segments in genomic DNAs representative of shared common ancestral regions. We utilized IBD approaches to map susceptibility loci associated with low-penetrance SNPs in high- GPT2,, residing within the IBD segments at 10q23.33-q24.1 and 16q11.2-q12.1, had statistically significant differential expression in primary ESCC tissues and are likely involved in ESCC carcinogenesis. The importance of these IBD segments to the etiology and development of ESCC in high-risk areas requires further study with expanded sample sizes. This is the first report employing the pairing IBD approach for elucidation of the genetic basis of hereditary ESCC in Henan by applying high throughput SNP array analysis.
Introduction
Esophageal cancer (EC) is the third most prevalent gastrointestinal malignancy in the world. It is a deadly disease with 5-year survival rates ranging from 10 to 16% (1) . Esophageal squamous cell carcinoma (ESCC) is the major histologic subtype of EC. Annually, there are 462,000 reported new cases and 386,000 deaths; 75% of the patients die within one year of diagnosis (1) . The incidence of EC shows great geographical variation. Its high prevalence is of particular importance in Northern China. Worldwide, the south side of the Taihang Mountains in North-central China along the northern borders of Hebei, Henan and Shanxi Provinces forms one of the highest risk regions of EC (2) (3) (4) . In Linzhou County of Henan Province in 1993-1997, the age-standardized incidence rate of EC in males and females was 121/100,000 and 80/100,000, respectively (5) . Epidemiological studies suggest that environmental factors such as alcohol abuse, tobacco smoke and dietary carcinogens may play a substantial role in the etiology of EC (6, 7) . However, strong evidence from familial aggregation of EC in Yangcheng County and segregation analysis of EC in Yangquan indicate the existence of genetic susceptibility loci for EC predisposition (3, 8) . Historically, the Chaoshan people in Nanao, which is another high-risk region of EC in Southern China (9) , originally migrated from the Taihang Mountain region. The distinctly high EC incidence in the Chaoshan population further strengthens the etiologic role played by genetic components in familial EC. A third line of evidence supporting a causative role of genetic factors in familial EC comes from molecular genetic studies of loss of heterozygosity (LOH), SNP association, microarray profiling and BRCA2 germline mutations (10) (11) (12) (13) (14) .
Recent technological advances allow the identification of long regions of homozygosity in genomic DNAs using high-density SNP arrays. These homozygous regions, which may dictate the level of consanguinity of an individual, are referred to as identity-by-descent (IBD) segments, also known as autozygosity (15, 16) . The IBD segments represent the sharing of common sequences from an ancestor in those regions. Previous studies suggest that a high rate of consanguinity, which produces germline genomic homozygosity, is associated with cancers (17) (18) (19) (20) . A recent study using SNP array analysis showed that the signatures of autozygosity correlate with colorectal cancer (CRC) incidence, and the IBD regions may help localize the genes that contribute to CRC heritability (15) . However, IBD regions are difficult to locate without pedigree information. We hypothesized that the IBD approach is useful for mapping the common susceptibility locus with low-penetrance SNPs in hereditary ESCC patients in Henan, one of the highest ESCC risk regions in the world. Screening programs based on knowledge of the candidate cancer susceptibility locus may reduce cancer mortality by prevention. Thus, the long-term aim is to better understand the genetic basis for ESCC in Henan to achieve the ultimate goal of improving ESCC patient survival. used to validate the expression of PLCE1 (NM_016341.3), CYP2-C18 (NM_000772.2), SIAH1 (NM_001006610.1) and GPT2 (NM_001142466.1), as previously described (25) . Primer sequences and UPL probe number used are provided upon request.
Materials and methods

Samples
Results
IBD segments: individual germline genomic homozygosity with exceptionally long stretches of SNPs.
The germline homozygosity in 28 Henan FH + ESCC patients was explored by analysis with Affymetrix GeneChip Human mapping SNP array (~238K SNPs, Sty I). The IBD segment approach scores the individual germline homozygosity (IBD segments) by detection of long stretches of at least 2 Mb containing a minimum of 50 consecutive homozygous SNPs in the blood DNAs. These IBD segments were distributed across the genomes of the 28 FH + ESCC cases, 16 Henan normal controls and 45 individuals from the CHB HapMap datasets (Fig. 1A) . The threshold was set to a minimum of 2 Mb in length containing at least 50 consecutive homozygous SNPs. Longer average IBD segment length and higher average number of SNPs in IBD segments were also detected in the cases compared to the controls and CHB HapMap controls, when the threshold was set ranging from 20 to 50 consecutive homozygous SNPs (data not shown). A total of 26 IBD segments in the FH + ESCC samples having no overlap with the control and CHB HapMap were detected (data not shown). The physical map is based on the Human Feb. 2009 (GRCh37/ hg19) assembly (http://genome.ucsc.edu/cgi-bin/hgGateway). ESCC patients compared to the Henan controls and Henan control/CHB HapMap, when the threshold was set ranging from 2 to 3.5 Mb in length containing at least 50 consecutive homozygous SNPs, although the difference did not reach statistical significance ( Fig. 2A-a-d) . FH + ESCC patients had statistically significant longer average IBD segments compared to the Henan control/CHB HapMap, when the threshold was set to 4 Mb in length containing at least 50 consecutive homozygous SNPs ( Fig. 2A-e + ESCC patients (n=28) showed a trend of longer average IBD segments compared to the Henan controls (n=16), CHB HapMap (n=45) and Henan control/CHB HapMap (n=61), when the threshold was set ranging from 2 to 4 Mb in length containing at least 50 consecutive homozygous SNPs. (B) (a) Frequency (number of IBD segments per person) using the homozygosity mapping approach for bioinformatic analysis of case/case and control/control pairing, and (b) the average length of IBD per person was higher in the cases compared to the CHB HapMap dataset, but similar in the cases and the controls. (c) The FH + ESCC patients had statistically significant longer average IBD lengths compared to CHB HapMap alone and CHB HapMap/control. A longer length of IBD segments was also observed, when a comparison was carried out between the case and control, although the difference did not achieve statistical significance. (Fig. 1B) . When the bioinformatic analysis was carried out based on the homozygosity mapping approach of case/case and control/control pairing, the frequency (number of IBD segments per person) and average length of IBD per person were higher in the cases compared to the CHB HapMap dataset, but similar in the cases and controls from Henan (Fig. 2B-a and -b) . The FH + ESCC patients had statistically significant longer average IBD lengths compared to the CHB HapMap alone and the CHB HapMap/Control. A longer length of IBD segments was also observed, when a comparison was made between the cases and controls, although the difference did not reach statistical significance (Fig. 2B-c) .
Among the 28, 16 and 45 individuals in the case, control, and CHB HapMap groups, the numbers of pairs for calculation of sharing events were 378, 120 and 990, respectively. (Table III) .
Validation of target gene expression identified by pairing IBD analysis by quantitative RT-PCR.
To examine the differential gene expression profiling among familial ESCC cases from high-risk Mainland China and cases from moderate-risk Hong Kong, an oligonucleotide microarray analysis with the 28K gene chip prepared at the Genome Institute of Singapore, as previously described (26), was performed using 31 pairs of ESCC specimens from Henan (11 FH + , 10 FH -) and Hong Kong (10 cases) (data not shown). Four critical target genes at 10q23.33-q24.1 and 16q11.2-q12.1 (Table II) were chosen for further study to demonstrate their clinical and biological relevance after comparison for overlap between the two lists of candidate genes identified by pairing IBD analysis and microarray differential expression. Validation of target gene expression by quantitative RT-PCR demonstrated significant overexpression of PLCE1 and SIAH1, as well as downregulation of CYP2-C18 and GPT2 expression using GAPDH expression for normalization (Fig. 3) . Among the 31 pairs of ESCC cases, the frequencies of PLCE1 and SIAH1 overexpression were 64.5 (20/31) and 90.0% (27/30) , respectively, while the frequencies of GPT2 and CYP2-C18 downregulation were 80.6 (25/31) and 76.7% (23/30) in ESCC primary tumor tissues, respectively, when the threshold was set at a 2-fold difference. 
Discussion
Increased risk of cancer incidence has been observed in inbred populations (18, 20, 27) . An inbred population is characterized by the sharing of longer IBD segments. These observations raise the question as to whether germline homozygosity is involved in cancer predisposition, particularly in inherited cancer. Technological advances in SNP array provide the opportunity to address this issue by the identification of these long stretches of IBD segments among cancer patients. Homozygosity mapping was reported as an efficient strategy to map human recessive traits with the DNA of affected children from consanguineous marriages (28,29) . The information obtained from a single affected child of a first cousin marriage is the same as those using linkage mapping with a nuclear family with three affected children. By studying DNA of less than a dozen unrelated, affected inbred individuals, homozygosity mapping makes it possible to map recessive diseases (28) . An example of the application of homozygosity mapping of five unrelated consanguineous families with autosomal recessive cutis laxa (ARCL) identified a candidate region on chromosome 17q25, and disease-causing mutations in PYCR1 were detected by high-throughput sequencing of the candidate region (29) . China is one of the highest risk regions of EC worldwide; the reported age-standardized incidence rate of EC in males and females was 37.9/100,000 and 12.0/100,000, respectively, in 2002 (1). The Taihang-Hebei-Henan-Shanxi area in Northcentral China forms an extraordinarily high risk region for this type of cancer (2-4). The age-standardized incidence rate of EC in males and females was ~3-fold and 6.5-fold higher, respectively, in Linzhou County of Henan Province in 1993-1997 compared to that in other parts of China (5) . There was an ~10-fold increase in esophageal carcinoma incidence in these highest risk regions of the Taihang-Hebei-Henan-Shanxi area compared to a moderate-risk region such as Hong Kong. The present study used the homozygosity mapping approach of affected ESCC patients from those villages with exceptionally high incidence of ESCC. Consanguineous marriages in these villages were highly suspected as longer average IBD segments were observed in Henan villages among both the controls and cases (Fig. 2B-a and -b ; Table IV ). The presence of homozygous segments in an individual's genome can be explained by tracing one's parental lineage to a common ancestor. The first approach identified 26 non-overlapping IBD segments that fulfilled a threshold criteria set (50 SNPs, 2 Mb) in the present study of FH + ESCC cases from Henan. Two individuals are identical by descent at a locus, when they share the same genetic materials from a common ancestor. The second approach in the present study detected excessive sharing of eight critical IBD regions in the genomes between two affected individuals with FH + ESCC. Table IV summarizes the results of IBD regions identified by individual homozygosity mapping and shared IBD segments in the case/case and control/control pairing approaches. Both approaches detected longer average IBD lengths in FH + ESCC cases, when compared to the CHB HapMap dataset (Table IV) . In the second approach, compared to the CHB HapMap dataset, there was a ~4.3-fold increase in the average IBD length per person in the Henan controls and FH + ESCC cases. There was an ~3.3-fold increase in the frequency of IBD segments in the Henan controls and FH + ESCC cases compared to the CHB HapMap dataset. The data suggested that populations from Henan villages (both FH + ESCC and controls) showed a higher rate of consanguinity compared to the CHB HapMap dataset. The critical regions detected by the pair-wise comparison provided additional information on the potential cancer susceptibility loci for ESCC development and should be further studied with a few affected inbred individuals or a higher number of FH + ESCC patients.
The only overlapping region, which may predispose an individual to develop ESCC, identified by both approaches was at 2q31.1-q32.2, in which a region of 21.1 Mb (chr 2: 170,290, 418, 198) identified by IBD detected in each individual alone was further narrowed down to 1.26 Mb containing one microRNA, MIR561, and two candidate genes Homo sapiens GULP, engulfment adaptor PTB domain containing 1 (GULP1), and Homo sapiens disrupted in renal carcinoma 1 (DIRC1) (chr 2: 188,440,696-189,700,120) by considering pairing information in the latter approach. GULP1 is an adapter protein necessary for the engulfment of apoptotic cells by phagocytes. Disruption of DIRC1 by translocation t(2;3)(q33;q21) is associated with familial clear cell renal cancer. The gene expression of GULP1 and DIRC1 in ESCC tumor tissues at 2q32.1-q32.2 was 0.89-fold and 1.27-fold, respectively, in our unpublished microarray dataset. Further study of candidate genes in this locus is necessary to verify their role in ESCC susceptibility. Another potential genetic Table IV . Summary of the results of the IBD regions identified by individual homozygosity mapping and sharing of homozygous segments in case/case and control/control pairing approaches. (17) . The potential cancer susceptibility loci identified in our data did not localize to loci of high penetrance cancer susceptibility genes such as BRCA1 at 17q12, BRCA2 at 13q14, or TP53 at 17p13-p15, but reside at regions similar to PLCE1 at 10q23 with low-penetrance susceptibility for cancer development. Combining the data from shared IBD segments by pairing analysis and the microarray profiling allowed us to narrow down the candidate genes for validation. These studies support the biological relevance of at least four target genes residing within the IBD segments at 10q23.33-q24.1 and 16q11.2-q12.1 having significant differential expression in primary ESCC tumors. PLCE1 is a phospholipase responsible for hydrolysis of phosphatidyl-inositol 4,5-bisphosphate regulating 1,2-diacylglycerol downstream signaling and an effector of GTPases, such as, Ras (33) . CYP2-C18, (cytochrome P450, family 2, subfamily C, polypeptide 18) located within a cluster of cytochrome P450 genes at 10q24, encodes one of the cytochrome P450 superfamily of enzymes, which are monooxygenases involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. SIAH1 (siah E3 ubiquitin protein ligase 1) is an E3 ligase. It may play a functional role in Parkinson's disease development, regulation of the cellular response to hypoxia and apoptosis. GPT2 [glutamic pyruvate transaminase (alanine aminotransferase 2)] encodes an enzyme for amino acid metabolism and gluconeogenesis. Importantly, PLCE1, GPT2, SIAH1 and CYP2-C18, appear to play an important role in ESCC tumorigenesis. Further in-depth genomic studies on these genes and others residing in these critical IBD regions are needed to elucidate their roles in ESCC. The increased length of germline genomic homozygosity associated with hereditary ESCC in Henan was observed. To strategically increase the power of the present study, we focused on high ESCC incidence region samples with ESCC FH + cases and with multiple ESCC cases within one family. The ancestries of Henan cases and control samples were also carefully matched to avoid false signals introduced by small differences in ancestry. However, the results were still limited by the small sample size. The importance of these IBD segments in the etiology and development of ESCC in highrisk areas requires further investigation with an expanded sample size for validation, and capture region targeted sequencing of the eight potential cancer susceptibility loci identified in this study is required to search and validate the importance of the disease-causing genetic variants responsible for familial ESCC development. Importantly, using a genetic IBD approach for the study of inherited ESCC, it is clear that host genetic susceptibility does indeed contribute to ESCC development in high-risk Henan.
